Lynk Pharmaceuticals Doses First Patient in Phase...
Category : Clinical Trial Update 11 July 2026Lynk Pharmaceuticals Advances Vitiligo Clinical Program Lynk Pharmaceuticals Co. Ltd. has announc...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Keenova Reports Positive Phase 3 Results for Xiafl...
Category : Clinical Trial Update 11 July 2026Xiaflex Shows Strong Results in Late-Stage Clinical Trial Keenova Therapeutics plc has announced...
Cipla Health Launches Omnigel Maxstrong, Expands P...
Category : Approval/Launch 8 July 2026Omnigel Introduces a New Pain Relief Product Cipla Health has announced the launch of Omnigel Max...
ReproNovo Doses First Participant in Phase 2 NORDI...
Category : Clinical Trial Update 8 July 2026ReproNovo Starts Phase 2 Clinical Trial in Europe ReproNovo has announced that the first particip...
EnteroBiotix Doses First Patient in Phase 2b RISE...
Category : Clinical Trial Update 8 July 2026EnteroBiotix Reaches a New Clinical Milestone EnteroBiotix Limited has announced that the first p...
Latest Newsletter Post
-
Keenova Reports Positive Phase 3 Re..
11 July 2026
-
Lynk Pharmaceuticals Doses First Pa..
11 July 2026
-
EnteroBiotix Doses First Patient in..
8 July 2026
-
ReproNovo Doses First Participant i..
8 July 2026
-
Cipla Health Launches Omnigel Maxst..
8 July 2026
